INOV(834261)

Search documents
一诺威(834261) - 公司章程
2025-09-11 09:16
| 第一章 总则 | 2 | | --- | --- | | 第二章 经营宗旨和范围 | 3 | | 第三章 公司股份 | 4 | | 第四章 股东和股东会 | 9 | | 第五章 董事会 | 31 | | 第六章 高级管理人员 | 47 | | 第七章 财务会计制度、利润分配和审计 | 48 | | 第八章 通知和公告 | 56 | | 第九章 合并、分立、增资、减资、解散和清算 | 57 | | 第十章 章程修改 | 61 | | 第十一章 附则 | 61 | 山东一诺威聚氨酯股份有限公司 章程 山东一诺威聚氨酯股份有限公司 章程 第一章 总则 第一条 为维护山东一诺威聚氨酯股份有限公司(以下简称"公司")及其 股东、职工和债权人的合法权益,规范公司的组织和行为,根据《中华人民共 和国公司法》(以下简称《公司法》)、《中华人民共和国证券法》(以下简 称《证券法》)、《北京证券交易所股票上市规则》以及国家有关法律、行政 法规及规范性文件等规定,制定本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司。 公司由山东东大一诺威聚氨酯有限公司通过净资产折股方式依法整体变更 设立,在淄博市市场监督 ...
一诺威(834261) - 董事变动公告
2025-09-11 09:16
证券代码:834261 证券简称:一诺威 公告编号:2025-094 山东一诺威聚氨酯股份有限公司董事变动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导 性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 一、董事任命的基本情况 山东一诺威聚氨酯股份有限公司(以下简称"公司")于 2025 年 9 月 10 日召开 2025 年第一次职工代表大会,审议通过了《关于选举公司第四届董事会职工代表董事 的议案》。 选举司书海先生为公司职工代表董事,任职期限至第四届董事会届满之日止,自 2025 年 9 月 10 日起生效。该人员持有公司股份 102,200 股,占公司股本的 0.04%,不 是失信联合惩戒对象。 (一)人员变动的合规性说明 本次董事变动符合法律法规、部门规章、业务规则和公司章程等规定。本次人员变 (上述人员简历详见附件) 二、董事离任的基本情况 本公司董事高振胜先生,因董事会调整,自 2025 年 9 月 9 日起不再担任董事。该 人员持有公司股份 112,000 股,占公司股本的 0.04%,不是失信联合惩戒对象,离任后 继续担任董事会秘 ...
一诺威(834261) - 2025年第一次职工代表大会决议公告
2025-09-11 09:16
证券代码:834261 证券简称:一诺威 公告编号:2025-093 山东一诺威聚氨酯股份有限公司 2025 年第一次职工代表大会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 (一) 会议召开情况 3、回避表决情况: 二、议案审议情况 本议案不涉及回避表决情况,无需回避表决。 (一)审议通过《关于选举公司第四届董事会职工代表董事的议案》 根据《中华人民共和国公司法》《上市公司章程指引》以及《北京证券交易 所股票上市规则》等相关法律法规、规范性文件的规定,结合公司实际情况,公 司拟不再设置监事会,并在董事会中设置一名职工代表董事。现推选司书海先生 担任公司第四届董事会职工代表董事,任期自本次会议审议通过之日起至第四届 董事会届满之日止。司书海先生符合《公司法》《北京证券交易所股票上市规则》 及《公司章程》规定的公司董事任职资格的要求,不属于失信联合惩戒对象。 1、议案内容: 2、议案表决结果: 同意 57 票,反对 0 票,弃权 0 票。 (二)会议出席情况 出席本次职 ...
一诺威(834261) - 北京国枫律师事务所关于山东一诺威聚氨酯股份有限公司2025年第一次临时股东会的法律意见书
2025-09-11 09:15
北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话:010-88004488/66090088 传真:010-66090016 邮编:100005 北京国枫律师事务所 关于山东一诺威聚氨酯股份有限公司 国枫律股字[2025]A0425 号 2025 年第一次临时股东会的 法律意见书 致:山东一诺威聚氨酯股份有限公司(贵公司) 一、本次会议的召集、召开程序 (一)本次会议的召集 对本法律意见书的出具,本所律师特作如下声明: 1.本所律师仅就本次会议的召集与召开程序、召集人和出席现场会议人员资格、 会议表决程序及表决结果的合法性发表意见,不对本次会议所审议的议案内容及该等议 案所表述的事实或数据的真实性、准确性和完整性发表意见; 2.本所律师无法对网络投票过程进行见证,参与本次会议网络投票的股东资格、 网络投票结果均由中国证券登记结算有限责任公司予以认证; 北京国枫律师事务所(以下简称"本所")接受贵公司的委托,指派律师出席并见 证贵公司 2025 年第一次临时股东会(以下简称"本次会议")。 1 3.本所及经办律师依据《证券法》《证券法律业务管理办法》《证券法律业务执 业规则》等规定及本法律意见书 ...
一诺威(834261) - 2025年第一次临时股东会决议公告
2025-09-11 09:15
证券代码:834261 证券简称:一诺威 公告编号:2025-090 山东一诺威聚氨酯股份有限公司 2025 年第一次临时股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 (一)会议召开情况 1.会议召开时间:2025 年 9 月 10 日 2.会议召开地点:公司二号楼一楼会议室 3.会议召开方式:现场投票和网络投票相结合 4.会议召集人:董事会 5.会议主持人:董事长徐军先生 6.召开情况合法合规的说明: 本次会议的召集、召开、议案审议程序等方面符合有关法律、行政法规、部 门规章、规范性文件和《公司章程》的规定。 (二)会议出席情况 出席和授权出席本次股东会的股东共 17 人,持有表决权的股份总数 161,631,104 股,占公司有表决权股份总数的 57.1764%。 其中通过网络投票参与本次股东会的股东共 0 人,持有表决权的股份总数 0 股,占公司有表决权股份总数的 0%。 (三)公司董事、监事、高级管理人员出席或列席股东会情况 1.公司在任董事 8 人,出 ...
体育产业板块高开,力盛体育、舒华体育涨停
Xin Lang Cai Jing· 2025-09-05 01:31
Group 1 - The sports industry sector opened high, with Lisheng Sports and Shuhua Sports reaching the daily limit up [1] - Huayang Racing surged over 20%, indicating strong investor interest [1] - Jinling Sports, Yeguangming, and Kangbiter all increased by over 10%, reflecting positive market sentiment [1] Group 2 - Other companies such as Zhongti Industry, Yinuowei, Gongchuang Turf, Kangliyuan, and Zhejiang Nature also experienced gains, contributing to the overall upward trend in the sector [1]
北交所公司上半年营收增长逾6% 7家公司净利润超亿元
Shen Zhen Shang Bao· 2025-09-03 16:55
Group 1 - The core viewpoint of the articles highlights the positive performance of companies listed on the Beijing Stock Exchange (北交所), with 274 companies reporting over 6% year-on-year revenue growth in the first half of the year, outperforming the overall A-share market [1] - In the second quarter, Beijing Stock Exchange companies achieved a total revenue of 50.547 billion yuan, representing a quarter-on-quarter growth of 21.75%, and a net profit of 3.133 billion yuan, with a quarter-on-quarter increase of 12.88% [1] - The top 50 companies by market capitalization on the Beijing Stock Exchange generated a total revenue of 37.474 billion yuan in the first half, with a year-on-year growth of 6.97%, and a net profit of 3.214 billion yuan, reflecting a year-on-year increase of 2.66% [1] Group 2 - Over 20 companies on the Beijing Stock Exchange plan to distribute mid-term dividends, with Jinbo Biological (锦波生物) proposing a cash dividend of 10 yuan per 10 shares, amounting to a total dividend of 115 million yuan [2] - The outlook for the Beijing Stock Exchange suggests a focus on technology growth, self-sufficiency, and sectors such as military and specialized small giant companies, which represent new productive forces [2] - Investment strategies for the second half of the year recommend focusing on new productive sectors like artificial intelligence and new consumption, as well as selecting companies based on financial metrics that show high growth potential and strong R&D investment [2]
北交所策略专题报告:北证2025中报“成绩单”:营收+6%净利+11%双增领跑,韧性凸显结构亮点纷呈
KAIYUAN SECURITIES· 2025-08-31 09:44
Group 1 - The overall performance of companies listed on the Beijing Stock Exchange (BSE) shows a significant recovery trend in 2025H1, with total revenue reaching 92.04 billion yuan, a year-on-year increase of 5.98%, and net profit attributable to shareholders of 6.608 billion yuan, up 11.45% year-on-year [10][12][17] - The gross profit margin for BSE companies in 2025H1 is 22.68%, a decrease of 0.98 percentage points, while the net profit margin is 7.18%, an increase of 0.35 percentage points [12][19] - Compared to the ChiNext and STAR Market, the recovery trend in revenue and net profit growth for BSE is stronger, with revenue growth rates of 11.20 percentage points, 4.43 percentage points, and 2.10 percentage points respectively, and net profit growth rates of 33.66 percentage points, 12.94 percentage points, and 10.45 percentage points respectively [17][18] Group 2 - In terms of industry performance, all five major sectors in BSE achieved year-on-year revenue growth in 2025H1, with the following growth rates: high-end equipment (3.88%), information technology (3.72%), chemical new materials (7.39%), consumer services (7.88%), and pharmaceutical biology (8.29%) [18][19] - The net profit growth rates for the information technology and chemical new materials sectors narrowed, with increases of 6.05 percentage points and 42.26 percentage points respectively [18] - The average revenue and net profit for the top 15 companies by revenue and net profit in BSE were 1.583 billion yuan and 101 million yuan, reflecting year-on-year growth of 10.44% and 12.80% respectively [23][24] Group 3 - The BSE 50 Index closed at 1,574.25 points with a TTM PE ratio of 76.91X, indicating a stable valuation center [34][36] - The average daily trading volume for BSE A-shares was 33.361 billion yuan, a decrease of 21.69% from the previous week, with a daily turnover rate of 6.83%, down 1.69 percentage points [33][35] - The report highlights the importance of focusing on technology growth, self-sufficiency, and specialized small giant companies in the BSE, while cautioning against high valuation non-tech companies that may face volatility risks [3][31]
北证公司半年报扫描:17家营收超10亿元,盈利面超八成
Zheng Quan Shi Bao Wang· 2025-08-29 13:53
Core Viewpoint - The companies listed on the Beijing Stock Exchange (BSE) demonstrated strong resilience and vitality in their 2025 semi-annual reports, with a significant number achieving substantial revenue and profit growth despite a complex market environment [1][2]. Revenue Performance - A total of 208 companies reported revenues exceeding 100 million yuan, with 17 companies surpassing 1 billion yuan, marking them as the "revenue leaders" of the BSE [2]. - Among these, Better Ray (贝特瑞) led with a revenue of 7.838 billion yuan, a year-on-year increase of 11.36%, and a net profit of 479 million yuan [2]. - Other notable companies in terms of revenue include Yinuowei (一诺威) at 3.550 billion yuan, Tongli Co. (同力股份) at 3.169 billion yuan, and Ying Tai Bio (颖泰生物) at 2.966 billion yuan [2]. Profitability - Out of 223 companies, 82.29% reported positive net profits, indicating a robust profitability landscape [3]. - Seven companies achieved net profits exceeding 100 million yuan, with Better Ray again leading at approximately 479 million yuan, followed by Development Technology (开发科技) at 395 million yuan [3]. - Jinbo Bio (锦波生物) reported a revenue of 859 million yuan, a 42.43% increase year-on-year, and a net profit of 392 million yuan, reflecting a 26.65% growth [3]. Profit Growth - Approximately 50% of companies, or 136 in total, reported year-on-year growth in net profits, with 27 companies doubling their profits [4]. - Shibibai (拾比佰) turned a profit with a net profit of 29.226 million yuan, attributed to increased sales driven by government policies and improved internal management [4]. - Chuangyuan Xinke (创远信科) achieved a revenue of 111 million yuan, a growth of 18.44%, and a net profit of 6.3153 million yuan, marking a significant increase of 354.24% [4]. Dividend Distribution - Over 20 companies announced interim dividend plans, reflecting a commitment to returning value to investors [6]. - Jinbo Bio plans to distribute a cash dividend of 10 yuan per 10 shares, totaling approximately 115 million yuan [6]. - Guoxin Technology (广信科技) proposed its first dividend since listing, with a plan to distribute 6.56 yuan per 10 shares, amounting to around 60 million yuan [6].
一诺威(834261) - 东吴证券股份有限公司关于山东一诺威聚氨酯股份有限公司2025年半年度持续督导跟踪报告
2025-08-29 11:05
一、持续督导工作概述 | | 股份有限公司关于山东一诺威聚氨 | | --- | --- | | | 酯股份有限公司 年度募集资金 2024 | | | 存放与使用情况的专项核查报告》 | | | 《东吴证券股份有限公司关于山东 | | | 一诺威聚氨酯股份有限公司使用闲 | | | 置募集资金购买理财产品的核查意 | | | 见》。 | | 7、其他需要说明的保荐工作情况 | 无 | 二、发现的问题及采取的措施 | 事项 | 存在的问题 | 采取的措施 | | --- | --- | --- | | 1、信息披露 | 无 | 不适用 | | 2、公司内部制度的建立和执行 | 无 | 不适用 | | 3、股东会董事会运作 | 无 | 不适用 | | 4、控股股东及实际控制人变动 | 无 | 不适用 | | 5、募集资金使用 | 无 | 不适用 | | 6、关联交易 | 无 | 不适用 | | 7、对外担保 | 无 | 不适用 | | 8、购买、出售资产 | 无 | 不适用 | | 9、对外投资 | 无 | 不适用 | | 10、发行人或者聘请的证券服务机构配合保荐 | 无 | 不适用 | | 工作情况 | | ...